Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isocal is a nutritionally complete oral nutritional supplement and medical food, specifically formulated for the dietary management of malnutrition and other medical conditions with increased nutritional needs that cannot be met through diet modification alone. It is designed for both oral consumption and tube feeding, providing a balanced blend of macronutrients (proteins, carbohydrates, fats including MCTs) and a comprehensive array of micronutrients (vitamins and minerals). Isocal is typically isotonic, lactose-free or low-lactose, and gluten-free, aiming to promote digestive tolerance and efficient nutrient absorption. It is manufactured by Nestlé Health Science and is used under medical supervision to support patients with inadequate oral intake due to various conditions such as cancer, stroke, anorexia, and for general tube feeding needs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Isocal.